SI
RETA
Sofinnova Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-322,471
| Closed | -$32.9M | – | 66 |
|
|
2023
Q2 | $32.9M | Sell |
322,471
-305,212
| -49% | -$31.1M | 2.15% | 16 |
|
|
2023
Q1 | $57.1M | Sell |
627,683
-364,346
| -37% | -$33.1M | 3.65% | 6 |
|
|
2022
Q4 | $37.7M | Buy |
992,029
+173,653
| +21% | +$6.6M | 2.24% | 13 |
|
|
2022
Q3 | $20.6M | Buy |
818,376
+34,525
| +4% | +$868K | 1.2% | 15 |
|
|
2022
Q2 | $23.8M | Buy |
783,851
+181,306
| +30% | +$5.51M | 1.98% | 12 |
|
|
2022
Q1 | $19.7M | Buy |
+602,545
| New | +$19.7M | 1.5% | 15 |
|
|
2021
Q4 | – | Sell |
-157,488
| Closed | -$15.8M | – | 79 |
|
|
2021
Q3 | $15.8M | Buy |
157,488
+77,887
| +98% | +$7.84M | 0.94% | 20 |
|
|
2021
Q2 | $11.3M | Sell |
79,601
-158,919
| -67% | -$22.5M | 0.65% | 35 |
|
|
2021
Q1 | $23.8M | Buy |
238,520
+89,583
| +60% | +$8.93M | 1.43% | 18 |
|
|
2020
Q4 | $18.4M | Buy |
148,937
+80,322
| +117% | +$9.93M | 1.1% | 19 |
|
|
2020
Q3 | $6.69M | Buy |
68,615
+55,580
| +426% | +$5.42M | 0.5% | 35 |
|
|
2020
Q2 | $2.03M | Buy |
+13,035
| New | +$2.03M | 0.13% | 54 |
|
|
2019
Q4 | – | Sell |
-148,669
| Closed | -$11.9M | – | 70 |
|
|
2019
Q3 | $11.9M | Buy |
148,669
+33,133
| +29% | +$2.66M | 1.08% | 23 |
|
|
2019
Q2 | $10.9M | Buy |
115,536
+50,505
| +78% | +$4.77M | 1% | 25 |
|
|
2019
Q1 | $5.56M | Sell |
65,031
-92,953
| -59% | -$7.95M | 0.54% | 34 |
|
|
2018
Q4 | $8.86M | Buy |
+157,984
| New | +$8.86M | 1.1% | 22 |
|
|
2018
Q3 | – | Sell |
-89,909
| Closed | -$3.14M | – | 65 |
|
|
2018
Q2 | $3.14M | Buy |
89,909
+60,526
| +206% | +$2.12M | 0.36% | 44 |
|
|
2018
Q1 | $603K | Buy |
+29,383
| New | +$603K | 0.1% | 27 |
|